PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40126C00094Eo 14398 BAA contract real aipe — University of Maryland, Baltimore

University of Maryland, Baltimore holds $67.5M across 131 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
University of Maryland, Baltimore
Recipient
Sep 29, 2027
PoP end
$750K
Obligated
$750K
Potential
334516
NAICS
AJ11
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40126C00094
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentUniversity of Maryland, Baltimore
CAGE1B0S2
UEIZ9CRZKD42ZT1
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSCAJ11
Place of performanceBALTIMORE MD
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitation1 FDABAA-26-00123
PoP startSep 30, 2026
PoP end (current)Sep 29, 2027
Obligated$750K
Current value$750K
Potential value$750K

Eo 14398 BAA Contract Real Aipe Real-World Evidence and Localized AI Imaging Testbed for Pulmonary Embolism is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by University of Maryland, Baltimore. Estimated value $750K ($750K obligated). Current period of performance ends Sep 29, 2027. Last award drew 1 bidder. Place of performance: BALTIMORE MD. Related solicitation 1 FDABAA-26-00123.

Eo 14398 baa contract real aipe real-world evidence and localized ai imaging testbed for pulmonary embolism

Recompete timing

Public
● Expiring in 347 days

Current PoP ends Sep 29, 2027 (347 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 75F40126C00094? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

University of Maryland, Baltimore — $67.5M obligated across 131 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($67.5M) · all agencies
Department of Health and Human Services (HHS)$52.9M · 78%Department of Veterans Affairs (VA)$8.9M · 13%Department of Defense (DOD)$3.8M · 6%Department of Transportation (DOT)$1.9M · 3%
Open full company profile →

Related awards

Same incumbent
36C24525C0037
IBC PROFESSIONAL CONSULTING SERVICES, OPTION YEAR.
$189K
Dec 5, 2026
75N90022C00017
STATE OF MARYLAND:1108634 [22-010136] SUPPORT FOR OFFICE OF AIDS RESEARCH INITIATIVE RESE…
$21.8M
Sep 27, 2027
75N91020C00007
RESOURCE FOR THE COLLECTION OF HUMAN TISSUE, CELLS, BIOFLUIDS AND EPIDEMIOLOGIC PROFILES F…
$8.1M
Sep 29, 2027
75N90024C00036
EVALUATION OF SEMAGLUTIDE SAFETY AND TOLERABILITY IN ADULTS WITH COCAINE USE DISORDER WITH…
$763K
Sep 29, 2027
75N90024C00035
ASSESSMENT OF LONG-ACTING STIMULANTS TO REDUCE HARM AND HIV TRANSMISSION IN METHAMPHETAMIN…
$733K
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40126C00094?

75F40126C00094 (Eo 14398 BAA contract real aipe) is a Fda Office Of Acq Grant Svcs award with a potential value of $750K, currently held by University of Maryland, Baltimore. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40126C00094?

Fda Office Of Acq Grant Svcs awarded 75F40126C00094 to University of Maryland, Baltimore (potential $750K).

Who is the incumbent on 75F40126C00094?

University of Maryland, Baltimore is the incumbent with $67.5M across 131 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does University of Maryland, Baltimore’s 75F40126C00094 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40126C00094? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40126C00094